Savara (SVRA) Change in Accured Expenses (2010 - 2026)

Savara (SVRA) reported Change in Accured Expenses of -$4.6 million for Q1 2026, down 47.24% year-over-year from -$8.8 million in Q1 2025, and down 227.09% quarter-over-quarter from $3.6 million in Q4 2025.

Savara (SVRA) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Change in Accured Expenses data on file, last reported at -$4.6 million in Q1 2026.

  • Change in Accured Expenses for Q1 2026 came in at -$4.6 million, down 47.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (up 82.06% YoY), and the FY2025 annual result was $4.8 million, up 14.4% from the prior year.
  • Change in Accured Expenses eased to -$4.6 million in Q1 2026 per SVRA's latest filing, from $3.6 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $3.6 million in Q4 2025 and troughed at -$4.6 million in Q1 2026.
  • A 5-year average of $505529.4 and a median of $1.2 million in 2025 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses soared 6075.0% in 2023, then plunged 308.83% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $445000.0 in 2022, then surged by 230.34% to $1.5 million in 2023, then soared by 53.74% to $2.3 million in 2024, then soared by 61.37% to $3.6 million in 2025, then tumbled by 227.09% to -$4.6 million in 2026.
  • Business Quant data shows SVRA's Change in Accured Expenses at -$4.6 million in Q1 2026, $3.6 million in Q4 2025, and $3.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Savara 1.39 Bn 1.39 Bn - -4.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.64 Mn
Mar 31, 2026 -4.64 Mn
Dec 31, 2025 3.65 Mn
Dec 31, 2025 3.65 Mn
Sep 30, 2025 3.12 Mn
Sep 30, 2025 3.12 Mn
Jun 30, 2025 1.19 Mn
Jun 30, 2025 1.19 Mn
Mar 31, 2025 -3.15 Mn
Mar 31, 2025 -3.15 Mn
Dec 31, 2024 2.26 Mn
Dec 31, 2024 2.26 Mn
Sep 30, 2024 1.38 Mn
Sep 30, 2024 1.38 Mn
Jun 30, 2024 1.34 Mn
Jun 30, 2024 1.34 Mn
Mar 31, 2024 -770,000.00
Mar 31, 2024 -770,000.00
Dec 31, 2023 1.47 Mn
Dec 31, 2023 1.47 Mn